North Shore University Hospital

Lake Success, New York 11042

0 studies enrolling now · 11 studies all time

What they study most

Acute Myelogenous Leukemia, Anaplastic Astrocytoma, Glioblastoma, Glioblastoma Multiforme, Intracranial Arteriosclerosis, Metastatic Breast Cancer, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Non-Small Cell Lung Cancer, Related Hematopoietic Stem Cell Donors, Stroke

Studies at this site

• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
• The National Myelodysplastic Syndromes (MDS) Study — Completed
• A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy — Stopped early
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) — Completed
• Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) — Completed
• The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma — Stopped early
• A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) — Completed
• Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy — Stopped early
• Stem Cell Related Donor Safety Study — Completed
• Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML — Completed